Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

Sarepta Therapeutics: Q1 Earnings Insights

Sarepta Therapeutics (NASDAQ:SRPT) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Sarepta Therapeutics beat estimated earnings by 55.91%, reporting an EPS of $-0.56 versus an estimate of $-1.27.

Revenue was up $63.90 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.36 which was followed by a 4.66% increase in the share price the next day.

Here's a look at Sarepta Therapeutics's past performance:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -1.13 -1.89 -1.29 -1.78
EPS Actual -0.77 -0.19 -1.52 -1.54
Revenue Estimate 198.61M 173.42M 162.64M 143.33M
Revenue Actual 201.46M 189.41M 164.09M 146.93M

To track all earnings releases for Sarepta Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.